Leo Yasinski

Leo Yasinski has extensive work experience in the pharmaceutical and healthcare industry. Leo started their career in 1996 as an Athletic Director and Mathematics Teacher in various school districts. In 2002, they joined Wyeth Pharmaceuticals as an Area Account Manager, where they achieved notable accomplishments and awards in sales. Leo then worked as a Consultant for ZARS Pharma, where they developed a Buy-n-Bill model for a product called Synera. In 2006, they joined Cubist Pharmaceuticals as a Clinical Business Manager and later took on roles as a Regional Access Manager and Regional Business Director. Leo then joined Merck in 2015 as an Associate Director of Managed Markets and Policy, where they led national account strategies and payor contracting for various pharmaceutical products. In 2019, Leo joined Tetraphase Pharmaceuticals, where they served as the Executive Director of Strategy & Market Access, responsible for developing outpatient strategy and partnership relations. Leo then joined La Jolla Pharmaceutical Company as a Senior Director, responsible for strategy and market access. Currently, Leo is the Executive Director of Strategy and Market Access at Innoviva Specialty Therapeutics, Inc. Overall, Leo has demonstrated expertise in strategy, market access, and partnership relations in the healthcare industry.

Leo Yasinski completed their education at Boise State University from 1992 to 1999. During this time, they obtained a Masters in Education with a focus on Mathematics, Curriculum and Instruction.